Neurologia

Amyloid imaging in prodromal Alzheimer's disease

Patients with mild cognitive impairment are at an increased risk of progression to Alzheimer's disease. However, not all patients with mild cognitive impairment progress, and it is difficult to accurately identify those patients who are in the prodromal stage of Alzheimer's disease. Koivunen and colleagues report that Pittsburgh compound-B, an amyloid-beta positron emission tomography ligand, predicts the progression of patients with mild cognitive impairment to Alzheimer's disease.
Approfondisci

 http://alzres.com/content/3/5/26...

Alzheimer's Research&Therapy